10th Indian Delegation to Dubai, Gitex & Expand North Star – World’s Largest Startup Investor Connect
IPO

DSM Fresh Food Limited’s IPO to open on Friday, September 26, 2025 with Price Band of Rs. 96 – Rs. 101 per Equity Share each of Face Value of Rs. 10 each

DSM Fresh Food Limited (“Company”), established in 2015, operates under the brand name Zappfresh and is one of the leading omnichannel retailer (Online B2C and offline B2B) of fresh meat and ready to cook/eat products.(chicken, mutton and seafood).

Zappfresh was founded with a vision to transform India’s highly fragmented meat retail sector and operates on an integrated supply chain model encompassing sourcing, processing, cold storage, and distribution. This ensures high-quality, hygienic, and fresh meat delivery to both retail consumers and HoReCa (Hotel, Restaurant, Catering) partners. 

The Company proposes to launch its Initial Public Offering (“IPO” or the “Offer”), scheduled to open on Friday, September 26, 2025, and close on Tuesday, September 30, 2025, with a price band of Rs. 96 – Rs. 101 per equity share of face value Rs. 10 each (“Equity Shares”). The Anchor Investor Bid/Issue Period will be held on Thursday, September 25, 2025, one working day prior to the Issue opening date.

Initial Public Offering up to 59,06,400 Equity shares of Rs. 10/- each (“Equity Shares”) DSM Fresh Foods Limited (“DSM” or the “Company”) at issue price band of Rs. 96- Rs. 101/- per equity share (“The Issue”). Out of the issue, 3,31,200 Equity Shares aggregating to Rs. 334.51 Lakhs will be reserved for subscription by Market Maker (“Market Maker Reservation Portion”). The Issue less the Market Maker Reservation Portion i.e Issue of 55,75,200 Equity shares of Face Value of Rs. 10 each at an Issue price band of Rs. 96 – Rs. 101/- per equity share aggregating to Rs. 5630.95 Lakhs is hereinafter referred to as the “Net Issue”, respectively of the Post Issue Paid up Equity Share Capital of the Company.

This Issue is being made through the Book Building Process, in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules, 1957, as amended (“SCRR”) read with Regulation 229 (2) of the SEBI ICDR Regulations and in compliance with Regulation 253 of the SEBI ICDR Regulations, wherein not more than 50.00% of the Net Issue shall be available for allocation on a proportionate basis to Qualified Institutional Buyers (“QIBs”) (the “QIB Portion”), provided that our Company may, in consultation with the BRLM Book Running Lead Manager, may allocate up to 60.00% of the QIB Portion to Anchor Investors on a discretionary basis in accordance with the SEBI ICDR Regulations (“Anchor Investor Portion”). One-third”), of the Anchor Investor which one-third Portion shall be reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the Anchor Investor Allocation Price in accordance with the SEBI ICDR Regulations. In the event of under-subscription, or non-allocation in the Anchor Investor Portion, the balance Equity Shares shall be added to the QIB Portion (other than the Anchor Investor Portion) (“Net QIB Portion”).  Further, 5.00% of the Net QIB Portion shall be available for allocation on a proportionate basis to Mutual Funds only, and the remainder of the Net QIB Portion shall be available for allocation on a proportionate basis to all QIB Bidders, including Mutual Funds, subject to valid Bids being received at or above the Issue Price. However, if the aggregate demand from Mutual Funds is less than 5.00% of the Net QIB Portion, the balance Equity Shares available for allocation in the Mutual Fund Portion will be added to the remaining Net QIB Portion for proportionate allocation to QIBs. Further, not less than 15.00% of the Net Offer Issue shall be available for allocation on a proportionate basis to Non-Institutional Investors, wherein (a) one third of the portion available to Non-Institutional Investors shall be reserved for Applicants with Application size of more than two lots and up to such lots equivalent to not more than ₹10 lakhs; (b) two third of the portion available to Non-Institutional Investors shall be reserved for Applicants with Application size of more than ₹10 lakhs; and (c) any unsubscribed portion in either of the sub-categories specified in clauses (a) or (b), may be allocated to Applicants in the other sub-category of Non-Institutional Investors; and not less than 35.00% of the Net Offer Issue shall be available for allocation to Retail Individual Investors who applies for minimum application size in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. Further, Equity Shares will be allocated on a proportionate basis to Eligible Employees applying under the Employee Reservation Portion, subject to valid Bids received from them at or above the Issue Price. All Bidders, other than Anchor Investors, are required to participate in the Offer Issue by mandatorily utilising the Application Supported by Blocked Amount (“ASBA”) process by providing details of their respective ASBA Account (as defined hereinafter) in which the corresponding Bid Amounts will be blocked by the Self Certified Syndicate Banks (“SCSBs”) or under the UPI Mechanism, as the case may be, to the extent of respective Bid Amounts. Anchor Investors are not permitted to participate in the Offer Issue through the ASBA process. For details, see “Issue Procedure” on page no. 264 of this Red Herring Prospectus. 

All Bidders (other than Anchor Investors) shall mandatorily participate in this Offer through the Application Supported by Block Amount (“ASBA”) process, and shall provide details of their respective bank account in which the Bid Amount will be blocked by the SCSBs. Anchor Investors are not permitted to participate in this Offer through the ASBA process.

The net proceeds from the Issue are proposed to be utilized towards funding the Company’s strategic growth initiatives, including working capital requirements of ₹ 25 crore, marketing expenditure of ₹15 crore, capital expenditure requirements of ₹11 crore and, and ₹3 crore towards inorganic growth opportunities through acquisitions and other strategic initiatives, as well as for general corporate purposes. 

Narnolia Financial Services Limited is the Book Running Lead Manager (“BRLM”) to the Offer. The Equity Shares of DSM Fresh Food Limited are proposed to be listed on SME platform of BSE (BSESME)

IPO
by Team SNFYI

Drug maker Allchem Lifescience has filed preliminary papers with markets regulator Sebi seeking its approval to raise funds through an initial public offering (IPO). The Gujarat-based company’s proposed IPO comprises fresh issue of equity shares aggregating up to Rs 190 crore and an offer for sale (OFS) of 71.55 lakh equity shares by promoters, according to the draft red herring prospectus (DRHP).  Those selling shares in the OFS are Kantilal Ramanlal Patel and Manisha Bipin Patel.  At present, promoters and promoter group entities hold 100 per cent stake in the company.  In its draft papers filed on Friday, Allchem Lifescience proposes to utilise proceeds from the fresh issue worth Rs 130 crore towards debt payment, while a portion will be used for general corporate purposes as well as to support the business requirements of the company.  AdvtIncorporated in 2017, Allchem Lifescience is an Indian manufacturer of active pharmaceutical ingredients (API) intermediates and speciality chemicals.  It specialises in the production of key starting materials (KSMs), generic API intermediates and specialty chemicals.  The company is a key player in manufacturing piperazine derivatives, which are critical raw materials for producing APIs like quetiapine, which is used in treating schizophrenia and bipolar disorder.  Over the years, Allchem Lifescience has developed the ability to manufacture 263 products which demonstrates their strong focus on different chemistries in organic chemical compounds.  The company’s focus has been to identify potential demand for products, in particular, products that are difficult to source in India or which being import substitutes are not easily available, develop such products and scale up production once the demand is in place.  The company has a manufacturing facility in Vadodara, Gujarat.  Allchem Lifescience caters to prominent domestic and international customers, including Alembic Pharmaceuticals, Bond Chemical, Indoco Remedies, Micro Labs, MSN Laboratories, Nagase India, Neogen Chemicals, Neuland Laboratories, and Unichem Laboratories.  As of December 2024, the company served customers across 13 states in India and 22 countries overseas. As of FY24, it had 148 customers in India and 66 customers overseas.  AdvtOn the financial front, the company’s revenue from operations has grown at a compound annual growth rate (CAGR) of 12.75 per cent between FY22 and FY24. The revenue figures for the six months ended September 30, 2024 was at Rs 7.84 crore.  Additionally, the profit after tax (PAT) has grown at a CAGR of 28.65 per cent from March 31, 2022, to March 31, 2024. The PAT figures for the six-month ended September 2024 stood at Rs 1.09 crore. Source Link

IPO
by Team SNFYI

Sahasra Electronic Solutions Limited is an Electronic System Design and Manufacturing company that provides electronic system design and manufacturing (“ESDM”) services at its Noida plant. The company is poised for its initial public offering (IPO), with plans to raise INR 186.16 crores through the issuance of 65.78 lakh new shares. For its SME Initial Public Offering (IPO), Sahasra Electronic Solutions Limited has established a price band of Rs 269 to Rs 283 per share. The company’s shares will open for subscription on September 26, 2024 and closes on September 30, 2024. These will be listed on the NSE Emerge, with a projected listing date of Friday, October 4, 2024. Hem Securities Limited is the book running lead manager of the Sahasra Electronics Solutions IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The issue proceeds will be utilized in Funding Capital Expenditure towards the installation of additional plant and machinery at a new manufacturing facility situated at Bhiwadi, Rajasthan, Investment in the Subsidiary, Sahasra Semiconductors Private Limited, for financing its capital expenditure requirements for the installation of additional plant and machinery, to meet working capital requirements and general corporate purposes. Tuesday, October 1, 2024, the shares for the Sahasra Electronic Solutions IPO are anticipated to be allotted, and on Thursday, October 3, 2024, the shares will be credited to the demat account of the allottees. The IPO comprises 50% of the net issue for QIB, 35% for retail investors and 15% of the net issue for the NII segment. Retail investors need to contribute a minimum of Rs 1,13,200 considering the minimum lot size for an application is 400 shares. For HNIs, the minimum bidding size is two lots, or 800 shares, for a total investment of Rs 2,26,400 lakh at the upper price band. Sahasra Electronics Solutions Limited’s Revenue Rs.101.15 Crs and profit after tax (PAT) 32.63 Crs for the financial year ending with March 31, 2024. Sahasra Electronic Solutions provides products and solutions such as printed circuit board (“PCB”) assembly, Box Build, and LED lighting. Memory, IT accessories, computer and IT hardware. During FY 2024, the company exported over 80% of its products and solutions to global manufacturers in countries such as the United States of America, Rwanda, Tunisia, the United Kingdom, Germany, Canada, Austria, and Belgium. The company has a manufacturing capacity of 1.8 million units through its ISO9001 & EN 9100:2018 certified plant in Noida. Source Link

IPO
by Team SNFYI

Ahmedabad-based Aeron Composite Ltd, a leading company engaged in manufacturing and supply of fibreglass reinforced polymer products, is planning to raise up to Rs. 56.10 crores from its SME public issue. The company has received approval to launch its public issue on the NSE Emerge Platform of the National Stock Exchange. The public issue opens for subscription on August 28 and closes on August 30. Out of the proceeds of the public issue, Rs. 39 crores will be utilized to fund the capital expenditure requirements towards setting up a manufacturing unit at Mehsana, Gujarat and general corporate purposes. Hem Securities Ltd is the book-running lead manager of the issue. The initial public offering of Rs. 56.10 crore comprises a fresh issue of 44.88 lakh equity shares of face value of Rs. 10 each. Company has finalized price band of Rs. 121-125 per equity share for the public issue. The minimum lot size for retail investors is 1,000 shares, amounting to a minimum investment of Rs 1,25,000 at the upper price band of Rs. 125 per share. Retail investor quota for the IPO is kept at not less than 35% of the net offer, HNI quota is kept at not less than 15% of the offer and QIB portion is kept at not more than 50% of the offer. Aeron Composite Ltd Issue Opens Issue Price Issue Closes 28 August, 2024 Rs. 121-125 Per Equity Share 30 August, 2024 Incorporated in year 2011, Aeron Composite Ltd is engaged in the business of manufacturing and supplying Fiber Glass Reinforce Polymer Products, i.e. FRP products, including FRP Pultruded Products, FRP Moulded Gratings & FRP Rods tailored for various industrial applications. FRP product is a composite material consisting of a polymer matrix (resins) reinforced with fibres such as fibreglass, carbon or aramid. This combination offers benefits, including corrosion resistance, chemical resistance, high strength, lightweight properties, electrical and thermal non-conductivity, and ease of fabrication. Company provides comprehensive solution which includes conceptual design, prototype development, testing, manufacturing, logistic support, installation and after sales service. The company’s manufacturing facility, certified by ISO 9001:2015, is located in Saket Industrial Estate at Changodar, Ahmedabad and is spread over 26,320 square metres. The manufacturing facility is certified for the design, manufacture and supply of FRP pultruded products, FRP Handrails, FRP cable trays, FRP fencing, FRP moulded gratings, FRP Cross arm, FRP poles, FRP rods and module mounting structures for solar panels (MMS). Company exports to more than 30 countries Key Financial Performance:                                                            Figures in Rs.Crore Period Ended 29 Feb 2024 31 Mar 2023 31 Mar 2022 31 Mar 2021 Revenue from Operations 179.14 179.38 108.33 78.82 EBITDA & Margin 14.27 (7.97%) 9.82 (5.48%) 5.99 (5.53%) 6.11 (7.75%) Profit After Tax & Margin 9.42 (5.26%) 6.61 (3.69%) 3.62 (3.34%) 2.55 (3.24%) Net Worth 34.78 25.36 15.57 12.08 Reserves and Surplus 33.21 23.79 14.27 10.78 Company has reported excellent operational and financial performance over the years. The Company has witnessed a multi-fold growth in revenue and profitability over the years. For FY23-24 (till …